Palvella Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PVLA and other ETFs, options, and stocks.About PVLA
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform.
CEOWesley H. Kaupinen
CEOWesley H. Kaupinen
Employees14
Employees14
HeadquartersWayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded2015
Founded2015
Employees14
Employees14
PVLA Key Statistics
Market cap1.17B
Market cap1.17B
Price-Earnings ratio-7.82
Price-Earnings ratio-7.82
Dividend yield—
Dividend yield—
Average volume187.71K
Average volume187.71K
High today$99.40
High today$99.40
Low today$95.86
Low today$95.86
Open price$97.81
Open price$97.81
Volume188.86K
Volume188.86K
52 Week high$106.71
52 Week high$106.71
52 Week low$11.17
52 Week low$11.17
Stock Snapshot
The current Palvella Therapeutics(PVLA) stock price is $98.58, with a market capitalization of 1.17B. The stock trades at a price-to-earnings (P/E) ratio of -7.82.
On 2025-12-15, Palvella Therapeutics(PVLA) stock traded between a low of $95.86 and a high of $99.40. Shares are currently priced at $98.58, which is +2.8% above the low and -0.8% below the high.
The Palvella Therapeutics(PVLA)'s current trading volume is 188.86K, compared to an average daily volume of 187.71K.
In the last year, Palvella Therapeutics(PVLA) shares hit a 52-week high of $106.71 and a 52-week low of $11.17.
In the last year, Palvella Therapeutics(PVLA) shares hit a 52-week high of $106.71 and a 52-week low of $11.17.
Analyst ratings
100%
of 15 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own PVLA. This list is generated using Robinhood data, and it’s not a recommendation.